Approval of Respiratory Biologics Linked to Decline in Asthma Exacerbations

A study published in JAMA Network Open found that the approval of additional respiratory biologics for asthma treatment was associated with a significant decline in asthma exacerbations. Biological drugs represent a specialized group of medications designed for patients with asthma. Asthma exacerbations are sudden worsening of disease symptoms that often require medical care. The study results indicate a positive effect of these new drugs on asthma control in patients. The approval of new biological drugs expanded treatment options for people with asthma. These medications are designed for specific types of asthma that do not respond adequately to standard treatment.